The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksShield Thera Share News (STX)

Share Price Information for Shield Thera (STX)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1.55
Bid: 1.50
Ask: 1.60
Change: 0.00 (0.00%)
Spread: 0.10 (6.667%)
Open: 0.00
High: 0.00
Low: 0.00
Prev. Close: 1.55
STX Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

AIM WINNERS & LOSERS: Wressle boosts Europa Oil, Egdon and Union Jack

Thu, 16th Dec 2021 10:56

(Alliance News) - The following stocks are the leading risers and fallers on AIM in London on Thursday.

----------

AIM - WINNERS

----------

Shield Therapeutics PLC, up 27% at 37.00 pence, 12-month range 27.01p-66.00p. The Newcastle, England-based pharmaceutical company says patient access for its Accrufer iron deficiency product rises. Shield secures payer coverage with "several large pharmacy benefit managers" in US. This boosts Accrufer access to roughly 40 million patients.

----------

Europa Oil & Gas Holdings PLC, up 15% at 1.24 pence, 12-month range 1.00p-2.20p. Rises on production update from Wressle hydrocarbon development in North Lincolnshire. Wressle has produced at an average of 666 barrels of oil per day over last seven day period. In early 2022, testing will be completed to see "full potential of the well". Europa holds a 30% stake in Wressle. Egdon Resources PLC also owns 30% and Union Jack Oil PLC 40%. Egdon shares are up 11% and Union Jack up 8.4%.

----------

Ceres Power, up 8.1% at 1,005.00 pence, 12-month range 820.50p-1,626.00p. Credit Suisse starts coverage of the stock with an Outperform rating and 1,450p price target.

----------

AIM - LOSERS

----------

boohoo Group PLC, down 16% at 115.56 p, 12-month range 110.00p-378.90p. Retailer lowers sales and margins guidance due to Omicron uncertainty and as product return rates hit net sales. For the financial year ending February 28, boohoo now expects net sales growth in the 12% to 14% range, cut from previous guidance of a rise of 20% to 25%. In three months to November 30, net sale rise 10% annually to GBP506.2 million from GBP460.7 million. On a two-year basis, net sales are 53% higher. Shares fall to a roughly five-year low.

----------

By Eric Cunha; ericcunha@alliancenews.com

Copyright 2021 Alliance News Limited. All Rights Reserved.

More News
27 Sep 2021 14:17

EXECUTIVE CHANGES: Bank of Ireland CFO leaves; EMIS names new non-exec

EXECUTIVE CHANGES: Bank of Ireland CFO leaves; EMIS names new non-exec

Read more
17 Aug 2021 12:00

Shield Therapeutics swings to losses in first half

(Sharecast News) - Commercial-stage pharmaceutical company Shield Therapeutics reported first-half revenues of £0.5m in its interim results on Tuesday, falling from £8.9m year-on-year.

Read more
17 Aug 2021 11:23

AIM WINNERS & LOSERS: Sunrise results good; Surface gets brake deal

AIM WINNERS & LOSERS: Sunrise results good; Surface gets brake deal

Read more
17 Aug 2021 10:57

Shield Therapeutics shares fall as swings to loss in first half

Shield Therapeutics shares fall as swings to loss in first half

Read more
12 Aug 2021 19:25

TRADING UPDATES: Corcel buys Wo Wo Gap project; Amiad, UDG leave LSE

TRADING UPDATES: Corcel buys Wo Wo Gap project; Amiad, UDG leave LSE

Read more
12 Aug 2021 12:25

Shield Therapeutics inks exclusive licence for 'Accrufer' in Korea

(Sharecast News) - Commercial-stage pharmaceutical company Shield Therapeutics has entered into an exclusive licence agreement for 'Accrufer', it announced on Thursday, with Korea Pharma in South Korea.

Read more
9 Aug 2021 17:08

TRADING UPDATES: Netcall wins new deal; Sareum raises GBP1 million

TRADING UPDATES: Netcall wins new deal; Sareum raises GBP1 million

Read more
24 Jun 2021 19:56

TRADING UPDATES: Vitec and Allergy Therapeutics lift full-year outlook

TRADING UPDATES: Vitec and Allergy Therapeutics lift full-year outlook

Read more
18 Jun 2021 15:39

EXECUTIVE CHANGES: Trident Royalties picks ex-Glencore member as chair

EXECUTIVE CHANGES: Trident Royalties picks ex-Glencore member as chair

Read more
10 Jun 2021 16:12

UK shareholder meetings calendar - next 7 days

UK shareholder meetings calendar - next 7 days

Read more
28 May 2021 15:48

EXECUTIVE CHANGES: Mitchells & Butlers slims board following fundraise

EXECUTIVE CHANGES: Mitchells & Butlers slims board following fundraise

Read more
28 May 2021 13:37

Shield Therapeutics appoints industry veteran Greg Madison as CEO

(Sharecast News) - Commercial stage pharmaceutical company Shield Therapeutics announced on Friday that Greg Madison has been appointed as its chief executive officer, with effect from 1 June.

Read more
24 May 2021 14:44

IN BRIEF: SPAC TECC Capital looks to list on Aquis Stock Exchange

IN BRIEF: SPAC TECC Capital looks to list on Aquis Stock Exchange

Read more
21 May 2021 17:51

TRADING UPDATES: Arkle spots gold; SDCL seals USD177 million buy

TRADING UPDATES: Arkle spots gold; SDCL seals USD177 million buy

Read more
18 May 2021 19:15

TRADING UPDATES: Forterra to beat outlook; Nostrum revenue falls

TRADING UPDATES: Forterra to beat outlook; Nostrum revenue falls

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.